2025-05-05 - Analysis Report
## Microstrategy Inc. (MSTR) Stock Review

**0. Key Figures:**

* **Cumulative Return (MSTR):** 1185.65%
* **Cumulative Return (VOO):** 82.57%
* **Return Difference (MSTR - VOO):** 1103.09%
* **Relative Divergence:** 57.6% (based on historical min/max range)
* **Current Closing Price:** $350.34
* **Last Market Price:** $394.37 (Significant recent increase)


**1. Company Overview and Performance Comparison:**

MicroStrategy Incorporated is a publicly traded business intelligence company.  Its significantly higher cumulative return compared to the S&P 500 (VOO) indicates strong outperformance, though this is heavily influenced by recent performance.  The relative divergence shows that the current performance is in the upper 57.6th percentile of its historical range relative to the S&P 500.

**Alpha and Beta Analysis:**

The provided data shows highly volatile alpha and beta values.  Early years (2015-2017 to 2017-2019) show negative alpha and high beta, indicating underperformance relative to the market with high volatility. However, from 2018 onward, both alpha and beta increase significantly, suggesting market-beating returns with elevated risk. The exceptionally high values in 2022-2024 and 2023-2025 warrant further investigation into potential market conditions that drove such performance.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -25.0% | 56.6% | -0.1 | 3.5 |
| 2016-2018  | -21.0% | 62.6% | -0.2 | 3.4 |
| 2017-2019  | -23.0% | 62.6% | -0.4 | 3.8 |
| 2018-2020  | 135.0% | 62.6% | -0.6 | 10.4 |
| 2019-2021  | 170.0% | 71.0% | -0.6 | 14.6 |
| 2020-2022  | 16.0% | 72.7% | -0.0 | 3.8 |
| 2021-2023  | 9.0% | 72.7% | 3.3 | 17.0 |
| 2022-2024  | 1382.0%| 72.7% | 3.4 | 77.9 |
| 2023-2025  | 1114.0% | 66.5% | 1.0 | 94.2 |


**2. Recent Price Movement:**

* **Closing Price:** $350.34
* **Last Market Price:** $394.37 (a significant increase of $13.77 or 3.35% from the previous close)
* **5-day Moving Average:** $334.81
* **20-day Moving Average:** $303.99
* **60-day Moving Average:** $303.94

The price is currently above all three moving averages, suggesting a potential upward trend.  The substantial jump in the last market price points to a recent, rapid price increase, potentially driven by news or market sentiment not reflected in the other data.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4053 (Medium Risk)
* **RSI:** 64.80 (Approaching overbought territory)
* **PPO:** 2.16 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence Change:** +6.2 (Short-term upward trend)
* **Expected Return (2+ years):** 126.9% (significantly outperforming the S&P 500)

The combination of indicators points towards a potential short-term overbought condition, however the high expected return suggests the potential for continued strong performance. The significant price increase needs to be considered; it might be a short-term event or potentially signaling a larger trend shift.

**4. Recent Earnings Analysis:**

The provided earnings data shows consistent negative EPS, suggesting that the company is currently not profitable. Revenue remains relatively stable but low. This negative EPS trend contrasts sharply with the high stock price and cumulative returns, highlighting a potential disconnect between financial performance and market valuation.

| 날짜 | EPS | 매출 |
|---|---|---|
| 2024-10-31 | -1.72 | 0.12 B$ |
| 2024-08-06 | -5.74 | 0.11 B$ |
| 2024-05-01 | -3.09 | 0.12 B$ |
| 2023-11-01 | -10.09 | 0.13 B$ |
| 2024-10-31 | -1.01 | 0.13 B$ |


**5. Financial Information:**

The financial information reveals high profit margins despite negative ROE.  This suggests that the company may be generating profits from non-operating activities, which is not sustainable in the long term. A further investigation into the nature of these high margins and low or negative ROE is required.


| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.12B | 71.69% |
| 2024-09-30 | $0.12B | 70.41% |
| 2024-06-30 | $0.11B | 72.24% |
| 2024-03-31 | $0.12B | 73.96% |
| 2023-12-31 | $0.12B | 77.33% |

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $18.23B | -3.68% |
| 2024-09-30 | $3.77B | -9.01% |
| 2024-06-30 | $2.83B | -3.62% |
| 2024-03-31 | $2.40B | -2.21% |
| 2023-12-31 | $2.16B | 4.12% |


**6. Overall Analysis:**

MicroStrategy's stock has shown exceptional returns exceeding the S&P 500. However, this performance is significantly influenced by recent price volatility and doesn't align with its fundamental financial data, which shows consistent negative EPS and fluctuating ROE.  The high profit margins despite negative ROE needs careful scrutiny. The high beta indicates significant market risk. While the projected long-term returns are substantial, investors should proceed with caution, given the inconsistency between market performance and fundamental financials. Further investigation into the drivers of recent price surges and the company's long-term financial strategy is crucial before making any investment decisions.  The current high valuation appears to be primarily speculative.
